FEMCAP BARRIER CONTRACEPTIVE

FDA Premarket Approval P020041

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the femcap barrier contraceptive. The femcap is indicated for use by women of childbearing age who desire to prevent or postpone pregnancy.

DeviceFEMCAP BARRIER CONTRACEPTIVE
Generic NameCap, Cervical, Contraceptive
ApplicantFEMCAP, INC.
Date Received2002-09-30
Decision Date2003-03-28
Notice Date2003-10-28
PMAP020041
SupplementS
Product CodeLLQ 
Docket Number03M-0488
Advisory CommitteeObstetrics/Gynecology
Expedited ReviewNo
Combination Product No
Applicant Address FEMCAP, INC. 14058 Mira Montana Dr. del Mar, CA 92014-3455
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P020041Original Filing
S003 2013-03-08 Normal 180 Day Track No User Fee
S002 2011-07-14 Normal 180 Day Track No User Fee
S001 2005-09-02 Real-time Process

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.